Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Study to Assess the Safety, Tolerability, and Pharmacodynamics of RTA 402 in Patients With Hepatic Dysfunction
This study has been terminated.
( Enrollment discontinued after second cohort completed. )
Study NCT00550849 Information provided by Reata Pharmaceuticals, Inc.
First Received on October 26, 2007. Last Updated on November 6, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Digestive System Diseases
Interventions listed in this trial
Sponsors listed in this trial
Reata Pharmaceuticals, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers